Rep. Eliot Engel (D-NY) made a brief appearance Tuesday at a Congressional briefing, hosted by several TB advocacy organizations, highlighting tuberculosis and its continuation as a global health threat. He called the fact that TB hasn’t been eradicated “a sin,” and then briefly announced the newly formed U.S. House of Representatives TB Elimination Caucus – […]
Otsuka Pharmaceuticals is the top private funder of tuberculosis (TB) research and drug development in the world. Last year, Otsuka established a Geneva-based subsidiary – Otsuka SA – to serve as “the company’s central operations for developing and implementing public health policies and corporate social responsibility programs in connection with its global TB program,” according to the company’s website.
As part of our reporting in advance of World TB Day on Saturday (March 24), Science Speaks interviewed Patrizia Carlevaro, PhD, the leader of Otsuka SA, to discuss Otsuka’s latest research to address drug-resistant forms of TB, the world’s emerging tuberculosis “hotspots,” and other efforts by the subsidiary organization to tackle TB.
HIV
If the criteria for the selection announced Wednesday night of Vice President Mike Pence to lead the U.S. efforts to contain the spread of COVID-19 seemed […]
Tuberculosis
As a New Pandemic Spreads, World TB Day Reminds us of Unfinished Business – Efforts to fight the latest global health threat can come at the […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
A coalition of medical, health care, health policy and other groups are calling on the United States Congress to swiftly and meaningfully fund emergency multifaceted domestic […]